Physician profile
Jesse E Riley
NPI 1548532583
$5,501.99
in general payments reported to CMS, 2019-2025
27 companies · $3,144 in 2025
The $3,144 reported for 2025 was more than what 90% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $1,127 · 2021: $34.22 · 2022: $152 · 2023: $246 · 2024: $639 · 2025: $3,144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,082 · Travel and Lodging: $1,948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,081.75 |
| Travel and Lodging | $1,948.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,974.82 | 2019-2025 | Variax, Augment Injectable, Ortholoc 2 Lapifuse |
| Medical Device Business Services, INC. | $1,291.05 | 2025 | Motoband |
| Depuy Synthes Sales INC. | $446.44 | 2024-2025 | Motoband, Motoband Cp, Minibunion |
| Active Medical, LLC | $434.09 | 2020 | |
| Paratek Pharmaceuticals, INC. | $247.73 | 2022-2025 | Nuzyra |
| Crossroads Extremity Systems, LLC | $197.91 | 2020-2021 | |
| Bone Support INC. | $144.89 | 2025 | Ceramentbone Void Filler, Cerament G |
| Orthofix Medical, INC. | $93.09 | 2023-2025 | Physio-Stim |
| Solventum Corporation | $87.94 | 2024-2025 | Activ.A.C., 3m Cavilon, Prevena |
| Treace Medical Concepts, INC. | $80.43 | 2024-2025 | |
| Kci USA, INC. | $53.15 | 2022-2023 | Activ.A.C., Promogran Prisma, V.A.C. Dermatac |
| Organogenesis INC. | $50.33 | 2024 | |
| Nevro Corp. | $44.44 | 2020-2023 | Senza |
| Anika Therapeutics, INC. | $37.17 | 2022-2024 | Integrity, Tactoset |
| Alfasigma USA, INC. | $35.95 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $35.62 | 2019-2022 | |
| Mimedx Group, INC. | $33.33 | 2024 | |
| Fusion Orthopedics USA, LLC | $31.76 | 2024 | |
| Horizon Therapeutics Plc | $31.33 | 2020-2022 | |
| Tactile Systems Technology INC | $25.47 | 2019-2020 | |
| Ani Pharmaceuticals, INC. | $23.58 | 2025 | Purified Cortrophin Gel |
| Actelion Pharmaceuticals US, INC. | $22.73 | 2025 | Uptravi, Opsumit |
| Medtronic, INC. | $18.42 | 2025 | Inceptiv |
| Biowound Solutions, INC. | $17.38 | 2025 | Bio-Connekt |
| Paragon 28, INC. | $14.86 | 2025 | Silverback |
| Integra Lifesciences Corporation | $14.62 | 2022 | |
| Arthrosurface Incorporated | $13.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Riley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.